Skip to main content
. Author manuscript; available in PMC: 2023 Feb 11.
Published in final edited form as: Mult Scler. 2022 Oct 13;29(2):248–260. doi: 10.1177/13524585221127414

Figure 2: MEDAS and MSFC: Disease Course and Duration.

Figure 2:

Panels A and B illustrate the interaction between disease course and the MEDAS-MSFC relationship. Higher MEDAS score attenuates the negative impact of progressive disease course on MSFC. Panels C and D illustrate the relationship between MEDAS score, MSFC, and disease duration (≥14 years represents the top quartile of time since diagnosis). High MEDAS score attenuates the negative impact of disease duration on MSFC.